Back to News
Market Impact: 0.35
Pfizer Lifts FY26 Guidance; Reports Strong Growth Across Multiple Products
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookCompany Fundamentals
Pfizer reported third-quarter 2026 results, citing growth in its non-COVID portfolio and launched and acquired products. The company raised its full-year revenue and adjusted earnings guidance; the article provides no figures for the results or revised outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
PFE0.75
More News
- Pfizer hikes full-year outlook, taps company veteran as new CFO
- Pfizer earnings analysis: questions answered and next catalysts
- Stocks making the biggest moves midday: Apple, Palantir, Nvidia, Coinbase, Bloom Energy & more
- Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
- Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher
- Stock Movers: PFR, AAPL, BE (Podcast)